| RS71579841 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS71581025 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary von Willebrand disease, von Willebrand disease type 3 |
| RS71581941 |
SLCO1B1
|
Health Risk |
Pathogenic |
Rotor syndrome, SLCO1B1-related disorder |
| RS71581991 |
SLCO1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rotor syndrome, Rotor syndrome |
| RS71582882 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS71599965 |
ENAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta, Amelogenesis imperfecta |
| RS71639057 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Roussy-Lévy syndrome |
| RS71640247 |
SLC10A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bile acid malabsorption, primary |
| RS71640277 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Short stature due to growth hormone qualitative anomaly |
| RS71640285 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS7164127 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, OCA2-related disorder |
| RS71647804 |
FIGLA
|
Health Risk |
Pathogenic |
Premature ovarian failure 6, Premature ovarian failure 6 |
| RS71647808 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS71647813 |
LFNG
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondylocostal dysostosis 3, autosomal recessive |
| RS71653621 |
PARK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive early-onset Parkinson disease 7, Autosomal recessive early-onset Parkinson disease 7 |
| RS71653633 |
SLC6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic dopamine transporter deficiency syndrome, Tobacco addiction |
| RS7169142 |
KNL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS7170898 |
RPAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS71785313 |
APOL1
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Focal segmental glomerulosclerosis 4, susceptibility to |
| RS71799110 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS7190978 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS7192781 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, Brody myopathy |
| RS71929101 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS7196804 |
MYH11;NDE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Aortic aneurysm |
| RS7199464 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS7213707 |
SPNS2
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS7214082 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS72225459 |
GRM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 13, Autosomal recessive spinocerebellar ataxia 13 |
| RS7227375 |
NPC1
|
Health Risk |
Likely pathogenic |
— |
| RS7229488 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS7238500 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS724159823 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS724159826 |
LRP5
|
Health Risk |
Pathogenic |
Polycystic liver disease 1, Polycystic liver disease 4 with or without kidney cysts |
| RS724159828 |
PDHX
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS724159829 |
PDHX
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS724159830 |
PDHX
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS724159945 |
ETV6
|
Health Risk |
Pathogenic |
Hematologic neoplasm, Thrombocytopenia |
| RS724159946 |
ETV6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hematologic neoplasm, Thrombocytopenia |
| RS724159947 |
ETV6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hematologic neoplasm, Thrombocytopenia |
| RS724159948 |
DYRK1A
|
Health Risk |
Pathogenic |
6 conditions, DYRK1A-related intellectual disability syndrome |
| RS724159949 |
DYRK1A
|
Health Risk |
Pathogenic |
Absent or delayed speech development, Deeply set eye |
| RS724159950 |
DYRK1A
|
Health Risk |
Pathogenic |
Intellectual disability, Microcephaly |
| RS724159951 |
DYRK1A
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS724159952 |
DYRK1A
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS724159953 |
DYRK1A
|
Health Risk |
Pathogenic |
6 conditions, DYRK1A-related intellectual disability syndrome |
| RS724159954 |
DYRK1A
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS724159956 |
DYRK1A
|
Health Risk |
Pathogenic |
6 conditions, Intellectual disability |
| RS724159957 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS724159958 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2S, Charcot-Marie-Tooth disease |
| RS724159959 |
IGHMBP2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2S, Charcot-Marie-Tooth disease axonal type 2S |
| RS724159960 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2S, Inborn genetic diseases |
| RS724159961 |
MFAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 9 |
| RS724159962 |
FAR1
|
Health Risk |
Pathogenic |
Fatty acyl-CoA reductase 1 deficiency, Fatty acyl-CoA reductase 1 deficiency |
| RS724159963 |
FAR1
|
Health Risk |
Pathogenic |
Fatty acyl-CoA reductase 1 deficiency, Fatty acyl-CoA reductase 1 deficiency |
| RS724159964 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS724159965 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS724159969 |
AIMP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 3, AIMP1-related disorder |
| RS724159970 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Macular dystrophy with central cone involvement |
| RS724159971 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Macular dystrophy with central cone involvement |
| RS724159973 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS724159974 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS724159975 |
TUBGCP6
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS724159976 |
TUBGCP6
|
Health Risk |
Pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS724159978 |
RNF135
|
Health Risk |
Pathogenic |
Macrocephaly, macrosomia |
| RS724159979 |
PDHX
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS724159980 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS724159982 |
SCN1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS724159983 |
OPN1MW
|
Health Risk |
Pathogenic |
Deuteranomaly, Deuteranomaly |
| RS724159984 |
CDH3
|
Health Risk |
Pathogenic |
Hypotrichosis with juvenile macular dystrophy, Congenital hypotrichosis with juvenile macular dystrophy |
| RS724159985 |
CDH3
|
Health Risk |
Pathogenic |
EEM syndrome, Macular dystrophy |
| RS724159988 |
P3H2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopia, high |
| RS724159990 |
ABAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Inborn genetic diseases |
| RS724159991 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS724159992 |
ABAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS724159993 |
PIEZO2
|
Health Risk |
Pathogenic |
Gordon syndrome, Gordon syndrome |
| RS724159994 |
IGHMBP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2S, Charcot-Marie-Tooth disease |
| RS724159995 |
PLK4
|
Health Risk |
Pathogenic |
Microcephaly and chorioretinopathy 2, Microcephaly and chorioretinopathy 2 |
| RS724159996 |
PLK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly and chorioretinopathy 2, Microcephaly and chorioretinopathy 2 |
| RS724159997 |
TUBGCP6
|
Health Risk |
Pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS724159998 |
LEP
|
Health Risk |
Pathogenic |
Leptin dysfunction, Leptin dysfunction |
| RS724159999 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 6B, Peroxisome biogenesis disorder 6A (Zellweger) |
| RS724160000 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 6B, Peroxisome biogenesis disorder 6A (Zellweger) |
| RS724160001 |
PEX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 6B, Peroxisome biogenesis disorder 6A (Zellweger) |
| RS724160002 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 6B, Peroxisome biogenesis disorder 6A (Zellweger) |
| RS724160003 |
BPNT2
|
Health Risk |
Pathogenic |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS724160004 |
TGDS
|
Health Risk |
Pathogenic |
Catel-Manzke syndrome, Catel-Manzke syndrome |
| RS724160005 |
TGDS
|
Health Risk |
Pathogenic |
Catel-Manzke syndrome, Catel-Manzke syndrome |
| RS724160006 |
P3H2
|
Health Risk |
Pathogenic |
Myopia, high |
| RS724160008 |
ATP1A1
|
Health Risk |
Pathogenic |
Aldosterone-producing adrenal cortex adenoma, Aldosterone-producing adrenal cortex adenoma |
| RS724160009 |
ATP2B3
|
Health Risk |
Pathogenic |
Aldosterone-producing adrenal cortex adenoma, Aldosterone-producing adrenal cortex adenoma |
| RS724160010 |
ATP1A1
|
Health Risk |
Pathogenic |
Aldosterone-producing adrenal cortex adenoma, Aldosterone-producing adrenal cortex adenoma |
| RS724160011 |
ATP2B3
|
Health Risk |
Pathogenic |
Aldosterone-producing adrenal cortex adenoma, Aldosterone-producing adrenal cortex adenoma |
| RS724160012 |
ATP2B3
|
Health Risk |
Pathogenic |
Aldosterone-producing adrenal cortex adenoma, Aldosterone-producing adrenal cortex adenoma |
| RS724160013 |
PRKACA
|
Health Risk |
Pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS724160014 |
AIFM1
|
Health Risk |
Likely pathogenic |
Deafness, X-linked 5 |
| RS724160015 |
AIFM1
|
Health Risk |
Likely pathogenic |
Deafness, X-linked 5 |
| RS724160016 |
AIFM1
|
Health Risk |
Likely pathogenic |
Deafness, X-linked 5 |
| RS724160018 |
AIFM1
|
Health Risk |
Likely pathogenic |
Deafness, X-linked 5 |
| RS724160020 |
AIFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, X-linked 5 |
| RS724160021 |
AIFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, X-linked 5 |